diabetestalk.net

A Type 1 Diabetes Pill? Newest Sotagliflozin Trial Results

A Type 1 Diabetes Pill? Newest Sotagliflozin Trial Results

A Type 1 Diabetes Pill? Newest Sotagliflozin Trial Results

Research reveals improved A1c and weight loss benefits for people with type 1 diabetes on sotagliflozin, but a slightly increased risk of DKA
The American Diabetes Association’s (ADA) 77th Scientific Session in June convened key leaders in diabetes research to share findings on the latest drug developments. At the conference, Lexicon Pharmaceuticals presented full results from three major trials looking at the safety and effectiveness of sotagliflozin, a new kind of type 1 diabetes therapy (a pill!) currently undergoing clinical trials that is taken in addition to insulin.
Two studies Lexicon presented at ADA (called inTandem1 and inTandem2) investigated how different doses of sotagliflozin affect measures such as A1c and weight. Trial participants either got 400 mg of sotagliflozin, 200 mg of sotagliflozin, or placebo (a “nothing” pill). A third study not presented at ADA (called inTandem3) compared 400 mg of sotagliflozin to placebo.
Results from inTandem1 found a significantly greater proportion of people taking sotagliflozin benefitted from the new therapy – defined as reducing A1c to less than 7% with no instances of severe hypoglycemia (low blood sugar) or diabetic ketoacidosis (known as DKA – read more about it here). Specifically:
44% of people taking 400 mg sotagliflozin benefitted, compared to 34% of those taking 200 mg of sotagliflozin and only 22% in the placebo group.
People taking 400 mg of sotagliflozin (the highest dose) lost an average of 6 pounds over 6 months, versus 3.5 pounds lost in those taking 200 mg of sotagliflozin and 1.8 pounds gained i Continue reading

Rate this article
Total 1 ratings
Curcumin Extract for Prevention of Type 2 Diabetes

Curcumin Extract for Prevention of Type 2 Diabetes

Abstract
OBJECTIVE To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population.
RESEARCH DESIGN AND METHODS This randomized, double-blinded, placebo- controlled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in β-cell functions (homeostasis model assessment [HOMA]-β, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention.
RESULTS After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group.
CONCLUSIONS A 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor advers Continue reading

Prepping With Type 1 Diabetes

Prepping With Type 1 Diabetes

Type 1 diabetes — also called Juvenile Diabetes — shook our prepping plans to their foundations. While I was stockpiling food, learning to make cheese, and writing the occasional post for the Survival Mom, my 9 year-old daughter’s body was attacking itself and she was diagnosed with Type 1 Diabetes.
Just a short time later I found myself trying to find answers for prepping with Type 1 Diabetes.
A T1D diagnosis is a life sentence of finger pokes and insulin administration. And because it’s genetic, we now know our other children are at risk.
What’s a survival mom to do? I didn’t even wait for the shock to wear off before I took to the internet seeking advice from the preparedness community…and was extremely disappointed with the meager information available. (I’ve included the links to those I found even a little bit helpful to save you time.) Even expert Mormon preppers who have so much information and resources had little to offer.
NOTE: This post is specific to Type 1 Diabetes, NOT Type 2. Please keep the differences in mind when you post comments and suggestions. Finding ways to prepare for a serious disease like this is scary. Suggestions that simple adjustments, like changing the food we have stored, as if we wouldn’t have already done that if it would resolve the issue, are more hurtful than helpful.
*Disclaimer: I am not a doctor, attorney, engineer, moralist, spiritual adviser, survivalist, or millionaire. Use the attached links and their information at your own risk. I’ve simply put together what’s on the net and what I’ve personally experie Continue reading

Are Microbiome Changes a Cause or Symptom of Type 1 Diabetes?

Are Microbiome Changes a Cause or Symptom of Type 1 Diabetes?

Two years ago, I interviewed Alex Kostic, who was then a postdoctoral fellow at the Broad Institute of MIT and Harvard exploring the microbiome’s connection to type 1 diabetes. His work studying children in Finland and parts of neighboring Russia showed that the microbiomes of children with type 1 diabetes were drastically different from the microbiomes of those without the disease. Now Kostic is running his own lab at the Joslin Diabetes Center in Boston, and investigating questions such as whether or not the changes in the microbiome are causing disease or are merely a symptom of it. He is also looking at the microbiota of the Joslin medalists—those who have lived with type 1 diabetes for more than fifty years. About 20-30 percent of those medalists still produce a trace amount of insulin, and Kostic is trying to understand whether that insulin production can be explained by differences in those medalists’ microbiomes.
Jessica Dunne, director of discovery research at JDRF, which is funding Kostic’s study of the medalists commented on the new lens that Kostic is bringing to the study of T1D. “We’re often thinking about how the microbiome is affecting the immune system. He took a different tack that we haven’t seen anyone take: what’s the role of the microbiome on beta cells? To me, it’s a completely novel approach; it’s very out of the box thinking in terms of how the microbiome can affect residual insulin production in type 1.” The question is, she continued, “can we reawaken those sleeping beta cells by modifying the microbiome?” Dr. George King Continue reading

Low Thyroid Hormone Raises Risk for Type 2 Diabetes

Low Thyroid Hormone Raises Risk for Type 2 Diabetes

People with prediabetes and low thyroid function were more than twice as likely to progress to full-blown type 2 diabetes compared to those with normal thyroid-hormone levels in a new study1 published September 30 in the journal BMC Medicine.
For the study, researchers from the Erasmus Medical Center in the Netherlands followed 8,492 adults, ages 54 to 74, for nearly eight years. At the start, 1,338 had prediabetes and 7,114 had normal blood sugar levels. After 7.9 years, 798 had developed type 2 diabetes. Overall, low thyroid function—even in the low-normal range—increased risk for diabetes by 13%. But among those with prediabetes, the risk for progressing to type 2 diabetes ranged from 15% for those with normal thyroid function to 35% for those with signs of low function. Even “low normal” thyroid functioning increased risk.
It’s the first large study to track low and low-normal thyroid function and diabetes risk. “There are no other studies addressing the relation between diabetes and thyroid function in the euthyroid range or in individuals with prediabetes,” the researchers note. Lead study author Layal Chaker, MD2 a Research and Curriculum Fellow at the Harvard T.H. Chan School of Public Health and a research fellow in the Department of Endocrinology and Epidemiology at the Erasmus Medical Center told EndocrineWeb that its too soon to recommend thyroid screening tests for people with prediabetes. And while treating low thyroid can help people with type 2 control their blood sugar, it’s not known whether treatment could prevent or delay it. “Our findi Continue reading

No more pages to load

Popular Articles

  • Type 1 diabetes trial patient insulin-free after treatment

    A new type 1 diabetes trial has left one participant completely insulin-free. The trial, conducted by the Diabetes Research Institute (DRI) at the University of Miami, involved the implantation of islet cells within a biological scaffold. Wendy Peacock, 43, underwent the procedure on August 18, 2015. For the first time since being diagnosed with type 1 diabetes at 17, Wendy can now naturally produ ...

  • Xultophy® Reported a Better Option than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Participants in the DUAL VII Clinical Trial

    Abu Dhabi, Uae (ots/PRNewswire) - Once-daily Xultophy® (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). This was reported by people with type 2 diabetes whose blood sugar was not controlled on insulin glargine U100 with metformin, and who completed quality-of-life questionnaires as part of the DUAL VII cl ...

  • Pouch of stem cells implanted in trial to cure type 1 diabetes

    Viacyte, privately-held, leading regenerative medicine company, announced today that the first patients have been implanted with the PEC-Direct™ product candidate, a novel islet cell replacement therapy in development as a functional cure for patients with type 1 diabetes who are at high risk for acute life-threatening complications. The first implant procedures of the clinical trial took place ...

  • New clinical trial could offer a functional cure for people with type 1 diabetes

    New clinical trial could offer a functional cure for people with type 1 diabetes New clinical trial could offer a functional cure for people with type 1 diabetes The ViaCyte trial is being run at three sites in North America, including University of Minnesota Health. Greg Romero (right) has to live with his type 1 diabetes all day, every day. But a new clinical trial offered through Universit ...

  • Mass. General Hospital launches phase II trial of BCG vaccine to reverse type 1 diabetes

    Mass. General Hospital launches phase II trial of BCG vaccine to reverse type 1 diabetes FDA approval of trial testing generic vaccine announced at ADA Scientific Sessions A phase II clinical trial testing the ability of the generic vaccine bacillus Calmette-Gurin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug Administration (FDA). The approval of t ...

  • A Website to Promote Physical Activity in People With Type 2 Diabetes Living in Remote or Rural Locations: Feasibility Pilot Randomized Controlled Trial

    Background: Research supports the use of Web-based interventions to promote physical activity in diabetes management. However, previous interventions have found poor levels of engagement or have not included health professionals and people with diabetes in the design of the tool. Objective: To develop and explore the feasibility and indicative effect of a Web-based physical activity promotion inte ...

  • Immunotherapy For Type 1 Diabetes Deemed Safe In First U.S. Trial

    In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes (T1D), led by UC San Francisco scientists and physicians, patients experienced no serious adverse reactions after receiving infusions of as many as 2.6 billion cells that had been specially selected for their potential to protect the body’s ability to produce insulin. T1D is an autoimmune disease in which the immun ...

  • Breakthrough pill can CURE diabetes: New drug fights both types of killer disease

    Handing hope to the millions of sufferers in the UK, the new study suggests that a “probiotic pill” - one containing live bacteria - can radically reduce blood glucose levels. In experiments researchers discovered that using a pill containing common bacteria found in the human gut can shift the control of glucose levels from the pancreas to the upper intestine. It is believed that this “rewi ...

  • Diabetes pill might replace injection to control blood sugar

    An injectable class of diabetes medication — called glucagon-like peptide-1 or GLP-1 — might one day be available in pill form, research suggests. Based on the results of a global phase 2 clinical trial, the study authors reported a significant drop in blood sugar levels for people on the oral medication, and no significant increase in low blood sugar levels (hypoglycemia) compared to a placeb ...

Related Articles